Is Allogene Therapeutics Inc (ALLO) Stock a Good Value Thursday?

A rating of 77 puts Allogene Therapeutics Inc (ALLO) near the top of the Healthcare sector according to InvestorsObserver. Allogene Therapeutics Inc's score of 77 means that it ranks higher than 77% of stocks in the sector. In addition, its overall score of 34 ranks it higher than 34% of all stocks.

ALLO has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on ALLO!

See Full ALLO Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 34 means the stock is more attractive than 34 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Allogene Therapeutics Inc Stock Today?

Allogene Therapeutics Inc (ALLO) stock is down -1.92% while the S&P 500 has gained 0.62% as of 11:36 AM on Thursday, Mar 21. ALLO is down -$0.09 from the previous closing price of $4.43 on volume of 543,497 shares. Over the past year the S&P 500 is up 33.53% while ALLO is down -13.69%. ALLO lost -$2.09 per share the over the last 12 months. Click Here to get the full Stock Report for Allogene Therapeutics Inc stock.